Diabetes Treatment Is Associated With Better Cognitive Function: The Age Disparity

Background: Diabetes mellitus (DM) is a recognised risk factor for cognitive dysfunction. The purpose of this study was to explore the relationship between active treatment for DM and cognitive function in middle-aged (< 60 years) and older adults (≥60 years), respectively.Methods: A total of...

Full description

Bibliographic Details
Main Authors: Keyi Wu, Huamin Liu, Jiazhen Zheng, Lianwu Zou, Shanyuan Gu, Rui Zhou, Zelin Yuan, Zhiwei Huang, Xianbo Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.753129/full
_version_ 1819283712317063168
author Keyi Wu
Huamin Liu
Jiazhen Zheng
Lianwu Zou
Shanyuan Gu
Rui Zhou
Zelin Yuan
Zhiwei Huang
Xianbo Wu
author_facet Keyi Wu
Huamin Liu
Jiazhen Zheng
Lianwu Zou
Shanyuan Gu
Rui Zhou
Zelin Yuan
Zhiwei Huang
Xianbo Wu
author_sort Keyi Wu
collection DOAJ
description Background: Diabetes mellitus (DM) is a recognised risk factor for cognitive dysfunction. The purpose of this study was to explore the relationship between active treatment for DM and cognitive function in middle-aged (< 60 years) and older adults (≥60 years), respectively.Methods: A total of 13,691 participants (58.55 ± 9.64 years, 47.40% of men) from the Chinese Health and Retirement Longitudinal Study (CHARLS) were included. The participants were classified into three groups according to whether or not they have diabetes and to their diabetes treatment status: diabetes-free, treated-diabetes and untreated-diabetes, in which the diabetes-free group was regarded as reference specially. Cognitive function was assessed by two interview-based measurements for mental intactness and episodic memory.Results: Compared with the participants in the diabetes-free group, the older participants in the treated-diabetes group had better performance in terms of mental intactness (β = 0.37, 95% CI = 0.04–0.70). No significant association was observed in the middle-aged participants. In the subgroup analyses, the lower cognitive score was only observed in people without depression, who had never smoked and drunk, and with a normal weight (body mass index: 18.5–23.9 kg/m2).Conclusion: The cognitive function of actively treated diabetic patients was better than that of patients without diabetes, but the improvement was significant only in elderly people. Depression, smoking, drinking, and an abnormal weight may attenuate this effect.
first_indexed 2024-12-24T01:35:50Z
format Article
id doaj.art-02d4dda90a014208a342928f8c578d93
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-12-24T01:35:50Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-02d4dda90a014208a342928f8c578d932022-12-21T17:22:12ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652022-01-011310.3389/fnagi.2021.753129753129Diabetes Treatment Is Associated With Better Cognitive Function: The Age DisparityKeyi Wu0Huamin Liu1Jiazhen Zheng2Lianwu Zou3Shanyuan Gu4Rui Zhou5Zelin Yuan6Zhiwei Huang7Xianbo Wu8Department of Epidemiology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, ChinaDepartment of Epidemiology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, ChinaDepartment of Epidemiology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, ChinaDepartment of Psychiatry, Baiyun Jingkang Hospital, Guangzhou, ChinaInpatient Department, Baiyun Jingkang Hospital, Guangzhou, ChinaDepartment of Epidemiology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, ChinaDepartment of Epidemiology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, ChinaDepartment of Epidemiology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, ChinaDepartment of Epidemiology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, ChinaBackground: Diabetes mellitus (DM) is a recognised risk factor for cognitive dysfunction. The purpose of this study was to explore the relationship between active treatment for DM and cognitive function in middle-aged (< 60 years) and older adults (≥60 years), respectively.Methods: A total of 13,691 participants (58.55 ± 9.64 years, 47.40% of men) from the Chinese Health and Retirement Longitudinal Study (CHARLS) were included. The participants were classified into three groups according to whether or not they have diabetes and to their diabetes treatment status: diabetes-free, treated-diabetes and untreated-diabetes, in which the diabetes-free group was regarded as reference specially. Cognitive function was assessed by two interview-based measurements for mental intactness and episodic memory.Results: Compared with the participants in the diabetes-free group, the older participants in the treated-diabetes group had better performance in terms of mental intactness (β = 0.37, 95% CI = 0.04–0.70). No significant association was observed in the middle-aged participants. In the subgroup analyses, the lower cognitive score was only observed in people without depression, who had never smoked and drunk, and with a normal weight (body mass index: 18.5–23.9 kg/m2).Conclusion: The cognitive function of actively treated diabetic patients was better than that of patients without diabetes, but the improvement was significant only in elderly people. Depression, smoking, drinking, and an abnormal weight may attenuate this effect.https://www.frontiersin.org/articles/10.3389/fnagi.2021.753129/fulldiabetescognitive declineepidemiologyantidiabetic treatmentageing
spellingShingle Keyi Wu
Huamin Liu
Jiazhen Zheng
Lianwu Zou
Shanyuan Gu
Rui Zhou
Zelin Yuan
Zhiwei Huang
Xianbo Wu
Diabetes Treatment Is Associated With Better Cognitive Function: The Age Disparity
Frontiers in Aging Neuroscience
diabetes
cognitive decline
epidemiology
antidiabetic treatment
ageing
title Diabetes Treatment Is Associated With Better Cognitive Function: The Age Disparity
title_full Diabetes Treatment Is Associated With Better Cognitive Function: The Age Disparity
title_fullStr Diabetes Treatment Is Associated With Better Cognitive Function: The Age Disparity
title_full_unstemmed Diabetes Treatment Is Associated With Better Cognitive Function: The Age Disparity
title_short Diabetes Treatment Is Associated With Better Cognitive Function: The Age Disparity
title_sort diabetes treatment is associated with better cognitive function the age disparity
topic diabetes
cognitive decline
epidemiology
antidiabetic treatment
ageing
url https://www.frontiersin.org/articles/10.3389/fnagi.2021.753129/full
work_keys_str_mv AT keyiwu diabetestreatmentisassociatedwithbettercognitivefunctiontheagedisparity
AT huaminliu diabetestreatmentisassociatedwithbettercognitivefunctiontheagedisparity
AT jiazhenzheng diabetestreatmentisassociatedwithbettercognitivefunctiontheagedisparity
AT lianwuzou diabetestreatmentisassociatedwithbettercognitivefunctiontheagedisparity
AT shanyuangu diabetestreatmentisassociatedwithbettercognitivefunctiontheagedisparity
AT ruizhou diabetestreatmentisassociatedwithbettercognitivefunctiontheagedisparity
AT zelinyuan diabetestreatmentisassociatedwithbettercognitivefunctiontheagedisparity
AT zhiweihuang diabetestreatmentisassociatedwithbettercognitivefunctiontheagedisparity
AT xianbowu diabetestreatmentisassociatedwithbettercognitivefunctiontheagedisparity